2019
DOI: 10.1016/j.canrad.2019.06.013
|View full text |Cite
|
Sign up to set email alerts
|

Plasmocytome solitaire osseux : expérience du service de radiothérapie de l’hôpital militaire d’instruction Mohammed-V de Rabat (Maroc)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 45 publications
0
2
0
Order By: Relevance
“…Three types of relapse were observed: development of a multiple myeloma (54%), local relapse (11%), appearance of new lesions (multiple plasmacytomas) in the absence of multiple myeloma (2%). The main predictors of recurrence are tumor size and the dose of radiotherapy delivered, with a higher risk for tumors larger than 5 cm and in case of radiotherapy with a dose less than or equal to 35 Gy [10] .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Three types of relapse were observed: development of a multiple myeloma (54%), local relapse (11%), appearance of new lesions (multiple plasmacytomas) in the absence of multiple myeloma (2%). The main predictors of recurrence are tumor size and the dose of radiotherapy delivered, with a higher risk for tumors larger than 5 cm and in case of radiotherapy with a dose less than or equal to 35 Gy [10] .…”
Section: Discussionmentioning
confidence: 99%
“…The prognosis of solitary bone plasmacytoma remains essentially dominated by the risk of occurrence of multiple myeloma. Age over 52 years, vertebral seat, existence or persistence of a monoclonal peak 1 year after treatment are the main risk factors [10] .…”
Section: Discussionmentioning
confidence: 99%